🍯 AI x Crypto x Longevity all in one

Welcome, humans. This is Ambrosia Path, the 5-min newsletter that wants to not die 😇

Here’s what we got for you today:

• Exclusive Interview with Rejuve.AI 

• Longevity Headlines

Rejuve.AI is on the Ambrosia Path

AI x Crypto x Longevity. Who’s building this?

Study Rejuve.AI 🤝

Learn all about what they’re building in this fascinating intersection 👇

Rejuve.AI: Rejuve.AI is a decentralized network for longevity research. With the help of advanced AI, we’re decoding the intricacies of aging, speeding up discoveries that pave the way for healthier and longer lives for all. 

Our mission is to empower you to own your longevity, offering personalized health insights and easier access to cutting-edge research and interventions.

Rejuve.AI: Our one-of-a-kind Longevity App is the key!

Through the App, you can input a wide range of health metrics and track your day-to-day in terms of nutrition, exercise, sleep, stress, etc. Simultaneously, our game-changing AI intervenes in two ways. 

First, it generates an accurate biological age for you based on the progression of the Hallmarks of Aging in your body. Secondly, it provides actionable, evidence-based insights to improve your biological age and, by extension, your health.

As you can see, now anyone in the world would be able to combat aging — to own their longevity.

Additionally, our AI models are crowdsourced, allowing researchers worldwide to partake in our groundbreaking research, earning dNFT as a reward for any data they contribute.

Rejuve.AI: The RJV token is longevity's bridge between Web2 and Web3, fostering a decentralized healthy and wellness economy to make longevity accessible and affordable to all. 

As you input health data and complete tasks on the Longevity App, you earn RJV as a reward. You could then use your RJV in the in-App Rewards Store in exchange for exclusive discounts on health-enhancing products and services such as genome sequencing, telomere testing, science-backed supplements, wearables, and more.

That’s a whole lot of longevity offerings finally on their way to becoming crypto-friendly thanks to RJV.

Rejuve.AI: On the industry front, we’re keen on forging partnerships with key longevity players worldwide. These partnerships can play out in different ways.

For example, our partners can list their products on the aforementioned Longevity App Rewards Store, bringing them closer to our vibrant community of health enthusiasts. A little further down the line, partnerships will also entail exchange of research to propel the entire industry forward.

Rejuve.AI: Speaking of partnerships, we’ve signed agreements with 13 leading longevity-focused companies, including TruDiagnostic, AVEA, and GlycanAge. Plus, we raised approximately $3.5 million in funding in 2023 alone. 

We’re also super proud of our growing Rejuve.AI community — closing in on 40,000 members soon across different social networks.

Rejuve.AI: Rejuve.AI leadership includes me as CEO and world-renowned AI pioneers: Dr. Deborah Duong as Chief Technology Officer, and Dr. Ben Goertzel as Chief AI Scientist.

Our team is steadily growing at 21 members, hailing from over 10 countries across all inhabited continents.

This diversity is in expertise too, as we have on board an amazing crew of AI engineers, data scientists, healthcare professionals, and business specialists.

Rejuve.AI: We're on the cusp of longevity's most exciting chapter! Life-altering breakthroughs await with developing therapies like epigenetic reprogramming and more to come thanks to billionaire investments in ventures like Altos Labs. 

At Rejuve.AI, we're committed to supporting these advances by uniting industry leaders and running AI-based simulations to accelerate the emergence of longevity breakthroughs. 

Meanwhile, we remain fixated on helping individuals optimize their healthspan through our Longevity App.

Rejuve.AI: Yes, we just released our roadmap for 2024. Milestones include the official launch of the Longevity App and kickoff of our Research Program and Data Commons.

We also just shared the great news with our community that our partners, Peptide Bioregulator, have officially integrated RJV into their online store as a payment option. More of our partners plus others in the pipeline will follow suit very soon.

Rejuve.AI: We’re always looking forward to growing our community! Be the first to know our latest updates by joining the Rejuve revolution on X, LinkedIn, Telegram, Instagram, Facebook, and YouTube.

Longevity Headlines

• Bryan Johnson will be attending Don’t Die in San Francisco, March 9th where people can get early access to his Blueprint Stack 🔥

• Mitochondria, crucial for energy and cellular functions, influence aging and diseases like cancer, diabetes, and neurodegeneration 😶‍🌫️

• Study links schizophrenia and aging cognitive decline to similar gene activity changes in brain, suggesting common biological roots √

• NeuroAge seeks new biomarkers as it develops drugs designed to reverse brain aging and combat dementia 🧠

• PreemptiveAI secures $6.4m funding and aims to use wearables data for real-time health mapping and early disease detection 💰

• Aeon Future Health moves into double the amount of clinic space, with a focus on longevity medicine 💊

• Lifespan Clinic has announced a joint venture with Healthspan Digital to co-launch Healthspan, a membership-based longevity program 🎫

• Sunbird Bio's APEX test aligns blood amyloid levels with brain deposits, promising early Alzheimer's detection 🕵️‍♂️

• Maximon, Marcuard Heritage, and GenTwo unveil new longevity investment opportunity via an AMC for professional investors 💵

That’s it for longevity news today folks! Have a fantastic day!

Hot Tip: If this email landed in your promotions folder, move it to primary to make sure you see the next edition!

Disclaimer: This information does not constitute health and/or financial advice or a recommendation and should not be considered as such